More than 95% of PCa specimens show PCA3 over-expression [194], and in addition to cancer tissue, PCA3 transcripts have also been identified in urine samples of patients with benign enlargement and malignant disease of the prostate [165]. Here, PCA3 is linked to posterior cortical atrophy.